Dear Colleague,
The management of critically ill patients continues to evolve. Recent advances in
biology coupled with careful observations in patients have provided new knowledge
of disease mechanisms and identified potential targets for intervention. However,
applying this information to improve outcomes from critical illness is still a work in
progress. Common problems include identifying optimal targets and approaches for
resuscitation to maintain tissue perfusion, defining the best therapeutic intervention
to sustain organ function, knowing when to intervene with extracorporeal support
techniques and when to initiate end of life care. A systematic approach to this problem
requires an understanding of the pathophysiologic mechanisms involved, techniques
to ascertain the stage of the disease and it relationship to the natural history, knowl-
edge of the therapeutic potential and experience with the optimal strategies that can
improve outcomes. Care of the critically ill patient requires a constant updating of
knowledge, skills and application of best practices. The twelfth international conference
on CRRT highlights the recent advances in our understanding of pathophysiology of
critical illness, emerging strategies in the management of sepsis, multi-organ failure,
acute kidney injury, technical advances in CRRT and the appropriate utilization of
these techniques.
As in past years, we have invited internationally recognized experts to discuss several
topics that reflect contemporary issues faced by the clinician treating patients in the ICU.
A review of the pathophysiology of organ failure is complemented by information on
how best to resuscitate patients. Kidney injury and its consequences, modulation of
organ dysfunction with extracorporeal techniques and innovations in cardiac and hepatic
support are other topics discussed. The emerging field of biomarkers is covered in a
series of lectures complemented by two workshops that will explore the utility of these
markers for diagnosis, prognosis and management of patients. New technology for the
diagnosis, monitoring and treatment of the critically ill patient is now being utilized and
its application is described. This year's program focuses on providing practical informa-
tion to translate new knowledge from the bench to the bedside. This is achieved with a
mix of invited lectures, workshops, poster sessions and panel discussions. Specific topics
on nursing care, nutritional support and other process of care elements are incorporated
in different sessions to promote multidisciplinary understanding and collaborative
approaches to patient care. A key goal of the conference is to equip participants with the
most up to date and practical knowledge for patient care. Consequently, we have intro-
duced new “hands-on” workshops designed to provide detailed instruction on the use of
specific equipment for extracorporeal support. More time has been allocated for net-
working to continue the tradition of multidisciplinary interactions, which are a highlight
of this conference. As always, we hope to provide the right environment to foster learning
and mutually beneficial communications and collaborations. We hope that while here,
you join us in sharing your knowledge and experience, as it is through multidisciplinary
interactions that we will gain a better understanding of critical illness and it is only
through our collective efforts that we will improve the lives of our patients.
On behalf of the organizing committee we are happy to welcome you to San Diegofor our Twefth Anniversary of the CRRT Conference.
Ravindra L Mehta, MDChairman, Organizing Committee
1
TwelfTH INTERNATIONAL CONFERENCE ON CONTINUOUS RENAL REPLACEMENT THERAPIES
USASteven R. Alexander, MD
Geraldine Biddle, RN, CNN, CPHQJoseph V. Bonventre, MD, PhD
Timothy E. Bunchman, MDJorge Cerda, MD
Glenn M. Chertow, MDWilliam R. Clark, MDStuart Goldstein, MD
Thomas A. Golper, MDDavid B. Hoyt, MD, FACS
Andre A. Kaplan, MDWilliam L. Macias, MD, PhD
Rhonda K. Martin, RN, MS, CCRN, CNS/ACNP-C
Bruce Mueller, PharmD, FCCPEmil P. Paganini, MD, FACP, FRCP
Maria Pascual, RN, BSN, MPHBrian J.G. Pereira, MD
David M. Ward, MD, FRCP
SOUTH AMERICAEmmanuel Burdmann, MD, PhD
CANADANoel Gibney, MD
Martine Leblanc, MD, FRCPCSheldon Tobe, MD
EUROPEBernard Jean-Marie Canaud, MD
Andrew Davenport, MDPatrick Honore, MD
Didier Journois, MD, PhDClaudio Ronco, MD
Miet Schetz, MD, PhDRaymond Vanholder, MD, PhD
JAPANTadao Akizawa, MD
Hiroyuki Hirasawa, MD, PhD
CHINALei-shi Li, MD, FHKCP
AUSTRALIAIan Baldwin, RN, MN, ACCCNRinaldo Bellomo, MD, FRACP
ORGANIZING COMMITTEECHAIRMAN
Ravindra L. Mehta, MD, FACP
On-site Registration Fees March 5-10, 2007Conference and Workshop Sessions March 7-10, 2007Welcome Reception (7:00 pm) Thursday, March 8, 2007Poster Mounting and Viewing (7:00 pm) Thursday, March 8, 2007Meet the Faculty/Big Band Swing Dance Reception (6:00 pm) Friday, March 9, 2007
NEW Hands-on Workshops (Electives)Gambro Prismaflex Wednesday, March 7, 2007Fresenius Saturday, March 10, 2007Gambro Prismaflex (condensed) Saturday, March 10, 2007CHF Solutions Saturday, March 10, 2007Pediatric Saturday, March 10, 2007
IMPORTANT CONFERENCE DATES
Endorsed by
The International Society of Nephrology
Acute Kidney Injury Network
INDIAVijay Kher, MD, DM, FAMS, FISN, FIMSA
Rajasekara Chakravarthi, MD, DNB
Participating Faculty ………………………………………………………………………2General Conference Information …………………………………………………………4Program - Plenary Sessions and Workshops ……………………………………………6Gambro Prismaflex Elective Workshop (Wednesday, H01) ……………………………6Elective Workshop List (Saturday, H02, H03, H04 & H05)……………………………11Poster List …………………………………………………………………………………13General Workshop “At a Glance” List …………………………………………………15Hotel Map …………………………………………………………………………………16
TABLE OF CONTENTS
2
PARTICIPATING FACULTYSteven R. Alexander, MD Professor of Pediatrics
Chief, Pediatric Nephrology
Lucille Packard Children's
Hospital at Stanford
Stanford University Medical Center
Stanford, CA USA
Inder S. Anand, MD, FRCP,DPhil Professor of Medicine
University of Minnesota
Director, Heart Failure Program
VA Medical Center, Minneapolis, MN
Minneapolis, MN USA
Linda Awdishu, BSc Pharm Transplant Specialist
Asst. Clinical Professor
The Skaggs School of Pharmacy and
Pharmaceutical Sciences, UCSD
Asst. Clinical Professor,
School of Pharmacy, UCSF
San Diego, CA USA
Ian Baldwin, RN, MN, PhD,ACCCN Professor of Intensive Care Nursing
Department of Intensive Care
Austin Hospital
RMIT University
Melbourne, VI AUSTRALIA
Jeffrey F Barletta, PharmD,FCCM Clinical Specialist- Critical Care
Department of Pharmacy
Spectrum Health
Grand Rapids, MI USA
Arthur Bradwell, MD University of Birmingham
Birmingham, WE UNITED KINGDOM
Patrick D. Brophy, MD, FAAP,FRCPC Pediatric Nephrology,
Dialysis & Transplantation
Co-Director, Pediatric Lupus Program,
Associate Director Pediatric Hemodialysis -
Acute Therapies
CS Mott Children's Hospital
University of Michigan
Ann Arbor, MI USA
Timothy E. Bunchman, MD Professor, Pediatric Nephrology &
Transplantation
Helen DeVos Children's Hospital
Grand Rapids, MI USA
Emmanuel Burdmann, MD, PhD Associate Professor,
Division of Nephrology
Sao Jose do Rio Preto Medical School
Sao Jose do Rio Preto, SP BRAZIL
Jorge Cerda, MD, FACP, FASN Clinical Associate Professor of Medicine
Albany Medical College and Capital
District Renal Physicians
Albany, NY USA
Rajasekara Chakravarthi,MD, DNB (Nephrology) Chief - Dept. of Nephrology
Care Hospitals
Institute of Medical Sciences Hyderabad
Hyderabad, AP INDIA
William R. Clark, MD Vice President,
Clinical Strategy and Therapy Development
Gambro Renal Products, Intensive Care
Clinical Assistant Professor of Medicine
Indiana University School of Medicine
Indianapolis, IN USA
Helen Currier, BSN, RN, CNN Assistant Director, Renal/Pheresis
Nursing Research Scholar, Center for
Clinical Research
Texas Children's Hospital
Houston, TX USA
Andrew Davenport, MD, MAConsultant Nephrologist
Honorary Senior Lecturer
Royal Free Hospital
London, ENGLAND (UK)
Daniel Davis, MD Clinical Professor
UCSD Emergency Medicine
San Diego, CA USA
Wilfred Druml, MD Medical University of Vienna, Austria
Vienna General Hospital
Vienna, AUSTRIA
James Fortenberry, MD Department of Pediatrics
Emory University School of Medicine
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia
Atlanta, GA USA
Noel Gibney, MD Professor and Director
Division of Critical Care Medicine
University of Alberta
Edmonton, Canada
Edmonton, AB CANADA
Stuart L. Goldstein, MD Associate Professor of Pediatrics
Baylor College of Medicine
Medical Director, Renal Dialysis Unit
Medical Director, Pheresis Service
Texas Children's Hospital
Houston, TX USA
Thomas A. Golper, MD Professor of Medicine
Nephrology Medical Director,
Medical Specialties Patient Care Center
Vanderbilt University Medical Center
Nashville, TN USA
Patty Graham, RN, MS,CCRN, CS Clinical Nurse Specialist
UCSD
San Diego, CA USA
Tarek Hassanein, MD Professor of Clinical Medicine and Surgery
Division of Gastroenterology and Hepatology
Chief of Clinical Hepatology
Medical Director of Liver Transplantation
UCSD Medical Center
San Diego, CA USA
Stefan Herget-Rosenthal, MD Klinik fur Nieren- und
Hochdruckkrankheiten
Medizinische Klinik
Universitatsklinikum
Essen, GERMANY
Jonathan Himmelfarb, MD Director, Division of Nephrology and
Transplantation Associate
Chair for Research, Department of Medicine
Maine Medical Center
Director, Center for Clinical and
Translational Research
Maine Medical Center Research Institute
Portland, ME USA
Patrick M. Honoré, MD Internist-Intensivist,ICU Director
Consultant in Intensive Care,
Senior Staff Member
ICU, Acute Medicine Department
St-Pierre Para-University Hospital
Ottignies-Louvain-La-Neuve
Br BELGIUM
Bertrand L. Jaber, MD, FASN Vice Chair for Clinical Affairs
Department of Medicine
Caritas St. Elizabeth's Medical Center
Associate Professor of Medicine
Tufts University School of Medicine
Caritas St. Elizabeth's Medical Center
Department of Medicine
Boston, MA USA
Oliver Joannes-Boyau, MD Anesthesiologist and intensivist
Consultant in ICU
Consultant in Hemofiltration,
Sepsis and Organ Support Therapies
University Hospital of Bordeaux
Pessac, FRANCE
Andre A. Kaplan, MD Professor of Medicine
University of Connecticut Health Center
Plainville, CT USA
John A. Kellum, MD, FACP,FCCM, FCCPProfessor, Critical Care Medicine
University of Pittsburgh School of Medicine
Pittsburgh, PA USA
Vijay Kher, MD Director
Dept. of Nephrology & Transplant Medicine
Fortis Hospital, B-1, Vasant Kunj
New Delhi, INDIA
Michael A. Kraus, MD Associate Professor of Clinical Medicine
Clinical Director, Division of Nephrology
Indiana University Medical Center
Indianapolis, IN USA
Martine Leblanc, MD Assistant Professor
University of Montreal
Chief of Nephrology
Maisonneuve-Rosemont Hospital
Montreal, QU CANADA
Lei-shi Li, MD, FHKCPResearch Institute of Nephrology
Nanjing University, School of Medicine
Nanjing, CHINA
Kathleen Liu, MD University of California, San Francisco
San Francisco, CA USA
Giancarlo Marenzi, MD Centro Cardiologico Monzino
Institute of Cardiology
University of Milan
Segrate, ITALY
3
PARTICIPATING FACULTYMark R. Marshall, MBChB,FRACPNephrologist, Department of
Renal Medicine
Middlemore Hospital
Honorary Senior Lecturer
Faculty of Medical and Health Sciences
South Auckland Clinical School
University of Auckland
Auckland, NEW ZEALAND
Rhonda K. Martin, RN, MS,MLT(ASCP) Nurse Practitioner
Clinical Nurse Specialist
Hepatology and Liver Transplantation
UCSD Medical Center
San Diego, CA USA
Ravindra L. Mehta, MBBS,MD, DM, FACPProfessor of Clinical Medicine
University of California, San Diego
School of Medicine
Associate Chair for Clinical Affairs,
Department of Medicine; Director, Clinical
Nephrology and Dialysis Programs
UCSD Medical Center
San Diego, CA USA
Bruce A. Mueller, PharmD,FCCPProfessor and Department Chair
Department of Clinical Sciences
College of Pharmacy
Associate Director,
Department of Pharmacy Services,
University Hospital
University of Michigan
Ann Arbor, MI USA
Mark D. Okusa, MD Chief, Division of Nephrology
University of Virginia
Charlottesville, VA USA
Emil P. Paganini, MD, FACP,FRCPProfessor of Medicine
Head, Section on Dialysis and
Extracorporeal Therapy
Cleveland Clinic Foundation
Cleveland, OH USA
Maria T. Pascual, RN, BSN,MPH UCSD Medical Center
San Diego, CA USA
Michael R. Pinsky, MD, CM,Dr hc, FCCP, FCCM Professor of Critical Care Medicine,
Bioengineering and Anesthesiology
University of Pittsburgh
Pittsburgh, PA USA
Joerg Rammo, MD Lipid-Liga
Bad Homburg, HE GERMANY
Claudio Ronco, MD Director, Department of Nephrology
St. Bortolo Hospital
Vicenza, ITALY
Edward Ross, MD Division of Nephrology,
Hypertension & Transplantation
University of Florida
Gainesville, FL USA
Bev Ryan, RN Edwards Lifesciences
Mississauga, ON CANADA
Miet Schetz, MD, PhD Associate Professor of Medicine,
University of Leuven
Senior Staff Member
Department of Intensive Care
University Hospital Gasthuisberg
Leuven, BELGIUM
Christian Schlaeper, MS Fresenius Medical Care
Walnut Creek, CA USA
Richard Sterns, MD University of Rochester
School of Medicine
Rochester, NY USA
Jordan M. Symons, MD Division of Pediatric Nephrology
Children's Hospital and
Regional Medical Center
Seattle, WA USA
Ciro Tetta, MD Director, Extracorporeal
Therapies Research Department
Bad Homburg, GERMANY
Sheldon W. Tobe, MD, FRCP(C) Associate Professor of Medicine, Nephrology
University of Toronto
Sunnybrook & Women's College Health
Sciences Centre
Toronto, ON CANADA
Ashita Tolwani, MD University of Alabama at Birmingham
Birmingham, AL USA
James A. Tumlin, MD FlowMedica Incorporated-Grant
GE Healthcare-Speakers Forum
Charlotte, NC USA
Gunars E. Valkirs, PhD Sr. Vice President, Discovery
Biosite Incorporated
San Diego, CA USA
Amit Varma, MD Chief Operating Officer &
Director Critical Care Medicine
Fortis Healthcare Limited
New Delhi, DE INDIA
David M. Ward, MD, FRCPProfessor of Clinical MedicineAssociate Medical Director of Kidney TransplantationDirector, Apheresis ProgramUCSD Medical Center
San Diego, CA USA
Lee C. Ware, RN Baxter Healthcare Corporation
Austin, TX USA
4
CONFERENCE DATES AND LOCATIONThe inclusive dates for all scientific sessions of the TWELFTH INTERNATIONAL CON-FERENCE ON RENAL REPLACEMENT THERAPIES are March 7-10, 2007. TheConference will be held at the Hotel del Coronado, 1500 Orange Ave., Coronado, California. Tel:(619) 435-6611, Fax: (619) 522-8238. www.hoteldel.com
Please note: Program Schedule may be subject to change
REGISTRATION INFORMATIONPlease visit our website to register, or use the form at the back of this brochure.All participants must register and pay the appropriate fee. Conference registrants will haveaccess to all scientific sessions and poster sessions. The registration fee includes general ses-sions, workshops, CME accreditation, conference syllabus, continental breakfasts, coffeebreaks, receptions and lunch on Thursday and Friday. Registration for those enrolled in the elec-tive workshop H01 Gambro Prismaflex will start at 8:00am Wednesday, March 7th. Generalregistration will begin on the evening of March 7th at 5:30pm. Poster Viewing will begin onThursday evening March 8th. For additional conference registration times see the program.
REGISTRATION FEES On-site RegistrationMarch 5 thru March 10, 2007
Physicians (MD, PhD, etc.) $ 730
Nurses/Dieticians/IndustryPharmacists/Residents*/Fellows* $ 540*with letter of verification from department head
ELECTIVE HANDS-ON WORKSHOPSNEW this year… we are providing elective “hands-on” workshops that will provide detailedinstructions on the use of CRRT equipment. Each workshop will provide training on the use ofthe device including setup, operations, monitoring and alarm conditions. Workshops have limitedslots to maximize opportunity for each participant to learn how to operate the equipment. Theseworkshops are a unique opportunity to acquire or refresh skills with different CRRT equipment.
Wednesday, March 7th 9:00am – 4:30pm HO1: Gambro Prismaflex Hands-On Workshop (includes lunch & breaks) $125
(this workshop has reached capacity and is closed)
Concurrent Hands-On Workshops (includes lunch & PM break) $75
Saturday, March 10th 1:00 – 5:00pm (select one - limited enrollment)
HO2: Fresenius Workshop “SLED , EDD and CRRT with the K Machines”Learn how to us the Fresenius system for CRRT, SLED and EDD
HO3: Gambro Prismaflex Workshop (condensed version of H01)(this workshop has reached capacity and is closed)Take advantage of an opportunity to work directly with an Accura or Aquarius to better understand the flexibility of these machines and the benefits they can offer you. Focus areasare: Machine set up, machine priming, machine programming and managing a treatment.
HO4: CHF Solutions “The Aquadex FlexFlow System”Use of Aquapheresis and the Aquadex FlexFlow in fluid overload states.
HO5: Pediatric Hands-on WorkshopHow to prescribe and deliver CRRT for neonates and pediatric patients, including machine setup operations monitoring and managing alarm conditions.
GUEST FEES $150Includes: Access to Exhibit Area, Welcome Receptions (Thursday), Meet the FacultyReception (Friday) and two Lunches (Thursday & Friday). Guests are not admitted to theGeneral Sessions or Workshops.
SOCIAL ACTIVITIES
Welcome/Exhibit Reception & Poster Session Thursday, March 8th - 7:00pm-8:30pmMeet and interact with your poster presenters and review the latest in equipment and prod-ucts at this informal reception. Upper and Lower Grande Hall
Meet the Faculty/Big Band Swing Dance Reception Friday, March 9th - 6:00pm-7:30pmMeet your faculty and network with your colleagues at the Hotel Del. Crown Room
GENERAL INFORMATION
Conference Registration Feedoes not include ElectiveHands-On Workshops.
5
TOURSThe conference has organized two optional tours for our accompanying guests. More informa-tion and registration is available at the conference registration desk.
Coronado Walking Tour Adult/Child $12Thursday, March 8th (10:45am-12:30pm) Meet on the front lawn
Our Coronado Tour is a 90-minute guided walking tour of historic areas in Coronado. Thetour will depart from the Glorietta Bay Inn (across the street from our conference site) andformer mansion of John D. Spreckels.
San Diego Trolley Car Tour Adult $30 Child $14Friday, March 9th (9:30am-11:30am)
Come along with San Diego's best tour conductors as they combine colorful anecdotes,humorous stories and well researched historical information into a fast moving two hour narrative that's both entertaining and educational.
ACCREDITATIONThis activity has been planned and implemented in accordance with the Essential Areas andpolicies of the Accreditation Council for Continuing Medical Education through the joint spon-sorship of the University of California, San Diego School of Medicine and Continuing RenalReplacement Therapies, Inc. The University of California, San Diego School of Medicine isaccredited by the ACCME to provide continuing medical education for physicians.
The University of California, San Diego School of Medicine designates this educational activ-ity (including elective Hands-On Workshops) for a maximum of 30.25 AMA PRA Category 1Credits™. Physicians should only claim credit commensurate with the extent of their partici-pation in the activity.
BRN: Nurses may claim credit for activities approved for AMA PRA Category 1 Credit™ inmost states, for up to 50% of the nursing requirement for recertification. This course is desig-nated for 30.25 AMA PRA Category 1 Credits™. (Provider # CME Category 1)
AAPA: Accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCMEto grant Category 1 credit.
CANCELLATION POLICYIf your registration must be cancelled, your fee, less $100 U.S. for administrative costs, will berefunded upon your written request. No refunds will be made after February 9, 2007. Allow 6-8 weeks for refund.
CONFERENCE OFFICE/INFORMATIONRES Seminars Phone: 858-272-1018 4425 Cass Street, Suite A Fax: 858-272-7687San Diego, CA 92109 USA Email: [email protected]
Conference Website: crrtronline.com
GENERAL INFORMATION
California Assembly Bill 1195 requires continuing medical education activities with patient care com-ponents to include curriculum in the subjects of cultural and linguistic competency. It is the intent ofthe bill, which went into effect on July 1, 2006, to encourage physicians and surgeons, CME providersin the state of California, and the Accreditation Council for Continuing Medical Education to meet thecultural and linguistic concerns of a diverse patient population through appropriate professional devel-opment. The planners, speakers and authors of this CME activity have been encouraged to addressissues relevant in their topic area. In addition, a variety of resources are available that address cultural and linguisticcompetency, some of which are included in your syllabus or handout materials. Additional resources and informationabout AB1195 can be found on our website at http://cme.ucsd.edu.
Views expressed by speakers at the CRRT Meeting are solely their own and do not necessarily reflectthe positions or policies of the CRRT, Inc or program committee. The program committee reserves theright to cancel or modify its programs as circumstances might dictate.
6
8:00-9:30 SIMULTANEOUS WORKSHOPS GROUP 1 A01* CRRT Systems I (C,N,AP)
Device demonstrations of features, setup, operation, monitoring and discontinuation
I. B. Braun Diapact IIII. Baxter - Edwards Lifesciences Critical Care Nephrology Alliance Accura/Aquarius
B02 Dialysis Dose Prescription and Delivery 1 (C,N)Operational characteristics influencing solute removal in IHD, PD and CRRT
William R. Clark, MDMark R. Marshall, MBChB, FRACPClaudio Ronco, MD
C03 Vascular Access /Membrane and Circuit 1 (C,N,AP)Principles of catheter choice, placement, maintenance, recognition and management ofcomplications, selection and use of membranesfor different applications, circuit design, setup and monitoring, prevention of infection
Ian Baldwin, RN, MN, PhD, ACCCNMichael A. Kraus, MDMaria T Pascual, RN BSN MPH
D04 Resuscitation 1 (C,N,AP)Principles of resuscitation for the critically ill patient
Daniel Davis, MDPatty Graham, RN, MS, CCRN, CS
E05 Pediatric CRRT: The Basics (I,N,AP)Technique requirement and application for use in children including neonates.
Steven R. Alexander, MDPatrick D. Brophy, MD, FAAP, FRCPCTimothy E. Bunchman, MDJordan M. Symons, MD
F06 Extracorporeal Techniques for Sepsis 1 (A)Pathophysiology of sepsis and rationale for use of extracorporeal support in treatment of sepsis. Experimental models for high permeability membranes, HVHF, VHVHF and hybrid therapies
Patrick M. Honoré, MDJohn A. Kellum, MD, FACP
G07 Plasma Exchange Therapy and Hybrid Techniques 1 (A)Principles of plasma exchange, sorbent based and hybrid therapies for extracorpo-real support. Results from experimental models and human studies
Arthur Bradwell, MDAndre A. Kaplan, MDJoerg Rammo, MD
9:30-9:45 Coffee Break - Garden Patio
9:45-11:15SIMULTANEOUS WORKSHOPSGROUP 2 A08* CRRT Systems II (C,N,AP)
Device demonstrations of features, setup, operation, monitoring and discontinuation.
I. CHF SolutionsII. NxStage Therapy System
B09 Anticoagulation 1: Mechanisms and Techniques (C)Anticoagulation regimens: Mechanisms, selection, prescription, monitoring and implementation.
Andrew Davenport, MD, MAOliver Joannes-Boyau, MDAshita Tolwani, MD
C10 Fluid Management 1 (I,N,AP)Principles of volume assessment, fluid removal and fluid regulation with different CRRT equipment
Ravindra L. Mehta, MDMichael R. Pinsky, MD
D11 Acid Base and Electrolyte Problems inthe Critically Ill 1 (I,N,AP)Principles and diagnosis of common acid base and electrolyte problems in the critically ill patient.
John A. Kellum, MDRichard Sterns, MDJames A. Tumlin, MD
E12 Organizational Aspects of CRRTPrograms 1: Development and Implementation (C,N,AP)Practical issues for organization and implementation of a CRRT program. Developing and implementing policies and protocols for CRRT
Ian Baldwin, RN, MN, PhD, ACCCNJorge Cerda, MDRhonda K. Martin, RN, MS, MLT(ASCP)
F13 Heart Failure and Cardio-Renal Syndrome 1 (I)Pathophysiology, recognition and managementstrategies for cardiac and renal failure in the critically ill patient
Inder S Anand, MDGiancarlo Marenzi, MDEmil P. Paganini, MD
G14 Therapy Comparisons 1: SLED vs. CRRT vs. PD (I,N,AP)Comparisons of operational characteristics including anticoagulation, membranes, solutions and flows and approaches for ongoing and future research
Rajasekara Chakravarthi, MD, DNB Thomas A. Golper, MDMark R. Marshall, MBChB, FRACP
11:15-12:45 Lunch Hosted by Conference - Windsor Lawn
WEDNESDAY, MARCH 78:00am Registration for Wednesday’s Elective Hands-On Workshop Outside the Coronet Room
9:00am-4:30pm HO1 Gambro Prismaflex Hands-On Workshop (closed - capacity reached)Training on setup, connections, operations, monitoring and troubleshooting for the Prismaflexplatform system for patients requiring various modalities of CRRT.
5:30-8:00pm Conference Registration Opens Upper Grande Hall Foyer
PROGRAM
7:00am-7:30pm Registration Upper Grande Hall Foyer
8:00am-4:15pm WORKSHOPS (open to all participants - see codes below)C= Core workshop, I = Intermediate, A = Advanced, N= Nurses, AP = Nurses & Allied Personnel)
Workshops designated by an asterisk (*) will be presented twice in different time slots. Workshops pre-sented in a series are marked with a “1” for a primary discussion in this area and “2” for a more complexor advanced discussion. Series workshops 1 and 2 can be taken subsequently (following each other) or theycan be taken independently (e.g. workshop 1 can be taken without taking workshop 2 and vice versa).
Coronet Room
THURSDAY MORNING, MARCH 8
Palm
Sunset
Crystal
Continental
Garden
Windsor
Coastal SurfPacific Tide
Palm
Sunset
Crystal
Continental
Garden
Windsor
Coastal SurfPacific Tide
7
THURSDAY AFTERNOON, MARCH 812:45-2:15
SIMULTANEOUS WORKSHOPS GROUP 3A15* CRRT Systems III (C,N,AP)
Device demonstrations of features, setup, operation, monitoring and discontinuation.
I. Gambro PrismaflexII. Fresenius Systems
B16 Solutions for CRRT 1 (I,N) Basic concepts for formulation and applicationof various solutions for pre-dilution, replacementand dialysate in critically ill patients.
Timothy E. Bunchman, MDMichael A. Kraus, MDSheldon W. Tobe, MD, FRCP(C)
C17 Drug Management 1 (I,N,AP)Dosing principles for critically ill patients andadjustments in extracorporeal support techniques.
Bruce A. Mueller, PharmD, FCCPMiet Schetz, MD, PhD
D18 Nutritional Assessment and Support 1 (I, N)Pathophysiology of malnutrition in criticallyill patients. Principles of nutritional assessment and support.
Wilfred Druml, MDMartine Leblanc, MD
E19 A Systems-based Approach to CRRT 1 (A,N,AP)Principles of systems based management strategiesand their application to CRRT. Approaches to reduce errors in therapy prescription and delivery.
Linda Awdishu, BSc, PharmRavindra L. Mehta, MD, FACP
F20 Liver and the Kidney 1 (A)Pathophysiology of hepatic failure and rationalefor use of different techniques for extracorporealsupport techniques (Cell based systems, MARS, CRRT) for hepatic support.
Tarek Hassanein, MDStefan Herget-Rosenthal, MD
G21 Biomarkers 1 (I,N) Principles and classification of biomarkers and their application for diagnosis and management of diseases. Criteria for using biomarkers as surrogate end points.
Bertrand L. Jaber, MDKathleen Liu, MD
2:15-2:30 Coffee Break - Garden Patio
2:30-4:00SIMULTANEOUS WORKSHOPS GROUP 4 A22* CRRT Systems I (C,N,AP)
Device demonstrations of features, setup, operation, monitoring and discontinuation.
I. B. Braun Diapact IIII. Baxter - Edwards Lifesciences Critical Care Nephrology Alliance Accura/Aquarius
B23 Dialysis Dose Prescription and Delivery 2 (I)Case based discussions of prescription of dose,modality choice and optimal dose delivery to match the therapy to the patients need.
William R. Clark, MDMark R. Marshall, MBChB, FRACP
C24 Vascular Access/Membrane and Circuit 2 (C,N,AP)Case based discussion of various factors influ-encing circuit longevity, membrane functionand troubleshooting for problems encountered.
Ian Baldwin, RN, MN, PhD, ACCCNMichael A. Kraus, MDMaria T Pascual, RN BSN MPH
D25 Resuscitation 2 (A,N,AP)Case studies using SIM-Man for resuscitation scenarios.
Daniel Davis, MDPatty Graham, RN, MS, CCRN, CS
E26 CRRT in the New Born: Principles and Application Nursing Issues in Pediatric CRRT (I,N,AP)Practical issues for setting up and maintaininga pediatric CRRT program. Policies and procedures and protocol based management.
Helen Currier, BSN, RN, CNNJordan M. Symons, MD
F27 Extracorporeal Techniques for Sepsis 2 (A)Technical considerations and practical appli-cation of extracorporeal support techniques for sepsis. Results of human studies for use of high permeability membranes, HVHF, VHVHF and hybrid techniques for sepsis.
Patrick M. Honoré, MDOliver Joannes-Boyau, MDClaudio Ronco, MDCiro Tetta, MD
G28 Plasma Exchange Therapy and Hybrid Techniques 2 (A)Case based discussion of practical applicationof plasma exchange, sorbent based and hybrid therapies for extracorporeal support.
Arthur Bradwell, MDAndre A. Kaplan, MDLei-shi Li, MD, FHKCP
SESSION I: PATIENT CHARACTERISTICS
OPENING SESSION - Upper Grande Hall
4:30 -7:00 Plenary 1 MINI-SYMPOSIAOrgan Dysfunction in the Critically Ill Patient
Co-chairs: Martine LeBlanc, MDNoel Gibney, MD
4:30-4:35 Opening RemarksRavindra L Mehta, MD, FACP
4:35-4:55 Predicting Lung Injury: Which MarkersKathleen Liu, MD
4:55-5:15 Cardio-Renal Syndrome Inder S. Anand, MD, FRCP, DPhil
5:15-5:35 Nutritional and Energy Requirements in Critical IllnessWilfred Druml, MD
5:35-5:55 Mechanisms of Ischemic AKIMark D. Okusa, MD
5:55-6:15 SPECIAL LECTURERenal Effects of Critical IllnessMichael Pinsky, MD
6:15-6:35 Kidney Disease: Common, Harmful, Treatable - Introducing “World Kidney Day”
6:35-7:00 Panel DiscussionModerator: Emil Paganini, MD
7:00-8:30 Welcome Reception/Exhibits OpenLower Grande Hall
Poster Viewing Upper Grande Hall
Palm
Sunset
Crystal
Continental
Garden
Windsor
Coastal SurfPacific Tide
Palm
Sunset
Crystal
Continental
Garden
Windsor
Coastal SurfPacific Tide
8
SESSION II: EMERGING CONCEPTS IN AKI AND CRITICAL CARE
7:25-7:30am AnnouncementsRavindra L. Mehta, MD, FACP
7:30- 9:45 Plenary 2 MINI-SYMPOSIAAcute Kidney Injury (AKI): What’s New?
Co-chairs: Miet Schetz, MDClaudio Ronco, MD
7:30-7:50 Metabolic Consequences of AKIJonathan Himmelfarb, MD
7:50-8:05 Genetic determinants in AKI Bertrand L. Jaber, MD
8:05-8:20 Pediatric AKI: Do Biomarkers Predict Injury?Stuart L. Goldstein, MD
8:20-8:35 Recovery from AKI: Predictive FactorsJonathan Himmelfarb, MD
8:35-8:50 Long Term Prognosis of Patients with AKI: Is Intensive Care Worth It?Wilfred Druml, MD
8:50-9:05 Management of Cirrhotic Ascites: Can We Prevent AKI?Mark Okusa, MD
9:05-9:20 Challenging Cases 1Richard Sterns, MD
9:20-9:45 SPECIAL LECTURE Acute Kidney Injury Network: A Strategy to Improve Outcomes from AKIRavindra L. Mehta, MD, FACP
9:45-10:00 Panel DiscussionModerator: Jorge Cerda, MD
10:00-10:30 Coffee Break - Exhibit Area
10:30-12:45 Plenary 3MINI-SYMPOSIAControversies in Management of the Critically Ill Patient
Co-chairs: Bruce Mueller, PharmDWilfred Druml, MD
10:30-10:50 Targeted Resuscitation: Strategies for SuccessMichael R. Pinsky, MD
10:50-11:10 Wet, Dry, and AKI: Just the FACTTs Kathleen Liu, MD
11:10-11:30 Rapid Response Teams: Do They Save Lives?Daniel Davis, MD
11:30-11:45 ELSO and PALISI TrialsJames Fortenberry, MD
11:45-12:00 Infection Control in the ICU: An UpdateMaria Pascual, RN BSN MPH
12:00-12:15 Challenging Cases 2Lei-shi Li, MD, FHKCP
12:15-12:45 SPECIAL LECTURE Acid-Base Physiology in CriticallyIll Patients: Traditional vs Modern ApproachesJohn Kellum, MD, FACP
12:45-1:00 Panel Discussion Moderator: Patrick Honoré, MD
1:00-2:15 Lunch Hosted by ConferenceCrown Room
FRIDAY MORNING, MARCH 9
PROGRAM
7:00am-4:00pm Registration Upper Grande Hall Foyer
Upper Grande Hall
Upper Grande Hall
9
2:15-3:45 SIMULTANEOUS WORKSHOPSGROUP 5 A29* CRRT Systems II (C,N,AP)
Device demonstrations of features, setup, operation, monitoring and discontinuation.
I. CHF SolutionsII. NxStage Therapy System
B30 Anticoagulation 2: Special Techniques Citrate (A)Comparison of various techniques for regional citrate anticoagulation includingrequirements, setup, monitoring and results.
Noel Gibney, MDAshita Tolwani, MDDavid M. Ward, MD, FRCP
C31 Fluid Management 2 (I,N,AP)Case based discussion of application of techniques for fluid regulation in CRRT.
Ravindra L. Mehta, MD, FACPMichael R. Pinsky, MD
D32 Acid Base and Electrolyte Problems inthe Critically Ill 2 (A)Case studies of common problems and strategies for management including use of dialytic therapies including CRRT.
Jonathan Himmelfarb, MDJohn A. Kellum, MD, FACPRichard Sterns, MD
E33 Organizational Aspects of CRRTPrograms 2: Development and Implementation (C,N,AP)Case studies of proven techniques for growing and enhancing a CRRT program. Multidisciplinary teams, collaborative practice,Financial models and other strategies for success.
Ian Baldwin, RN, MN, PhD, ACCCNJorge Cerda, MD, FACP, FASN
F34 Heart Failure and Cardio-renal Syndrome 2 (A)Technical considerations, practical applicationand results of different methods to treat heart failure and cardio-renal syndrome.
Inder S Anand, MD, FRCP, DPhilGiancarlo Marenzi, MDEmil P. Paganini, MD, FACP, FRCP
G35 Therapy Comparisons 2: SLED vs. CRRT vs. PD (A)Case Based Examples of SLED (daily and Continuous), PD (intermittent, tidal) and practical aspects for recognizing and managing complications and approaches for ongoing and future research.
Emmanuel Burdmann, MD, PhDVijay Kher, MDMark R. Marshall, MBChB, FRACP
3:45-4:00 Coffee Break - Exhibit Area
4:00-5:30 SIMULTANEOUS WORKSHOPS GROUP 6 A36* CRRT Systems III (C,N,AP)
Device demonstrations of features, setup, operation, monitoring and discontinuation.
I. Gambro PrismaflexII. Fresenius Systems
B37 Solutions for CRRT 2 (A) Case based discussions of applications of solutions for acid-base and metabolic control,electrolyte and divalent ion homeostasis.
Jeffrey F Barletta, PharmD, FCCMTimothy E. Bunchman, MDEdward Ross, MD
Sheldon W. Tobe, MD, FRCP(C)C38 Drug Management 2 (I,N)
Case based discussion of practical aspects for drug prescription, delivery and managementof drug interactions in CRRT.
Thomas A. Golper, MDMiet Schetz, MD, PhD
D39 Nutritional Assessment and Support 2 (I)Case based discussion of technical and practical considerations for nutritional support with CRRT.
Wilfred Druml, MDMartine Leblanc, MDBruce A. Mueller, PharmD, FCCP
E40 A Systems-based Approach to CRRT 2(A,N,AP)Case studies of applications of systems based approaches for problem solving and continuous quality improvement in CRRT. Strategies to implement best practices to improve patient safety and outcomes.
Linda Awdishu, BSc PharmRavindra L. Mehta, MD, FACP
F41 Liver and Kidney 2: Hepatic Support (A)Technical considerations, practical application and results of different methodsof hepatic support for patients with hepatic failure and hepatorenal syndrome.
Andrew Davenport, MD, MAStefan Herget-Rosenthal, MDRhonda K. Martin, RN, MS, MLT(ASCP)
G42 Biomarkers 2 (A)Applications for biomarkers as diagnostics and theranostics in AKI and crtitical illness.
Kathleen Liu, MDGunars E. Valkirs, PhD
5:30 Adjourn
FRIDAY AFTERNOON, MARCH 9
PROGRAM
6:00-7:30 Meet the Faculty andBig Band and Swing Dance ReceptionCrown Room
Palm
Sunset
Crystal
Continental
Garden
Windsor
Coastal SurfPacific Tide
Palm
Sunset
Crystal
Continental
Garden
Windsor
Coastal SurfPacific Tide
10
7:25-7:30 Announcements
7:30-10:00 Plenary 4MINI-SYMPOSIAChallenges and Controversies in Renal Support and CRRT
Co-chairs: Prof. Le-Shi Li, MDIan Baldwin, RN, MN, PhD, ACCCN
7:30-7:50 Ultrafiltration for Heart Failure: What is the Evidence?Gianacarlo Marenzi, MD
7:50-8:10 Dose of Dialysis in CRRT: Resultsof a Randomized Controlled TrialAshita Tolwani, MD
8:10-8:30 Advances in Renal Support: Literature Review Noel Gibney, MD
8:30-8:45 Fluid Balance Errors with CRRTMachines: Should We Have Standards?Claudio Ronco, MD
8:45-9:00 Applying Pharmacodynamic Principles to CRRT PatientsBruce Mueller, PharmD, FCCP
9:00-9:15 Challenging Cases 3Vijay Kher, MD
9:15-9:45 SPECIAL LECTUREDebateContrast Nephropathy: To Filter or Not?Gianacarlo Marenzi, MDJames Tumlin, MD
9:45-10:00 Panel DiscussionModerator: Thomas Golper, MD
10:00-10:20 Coffee Break - Exhibit Area
10:20-12:50 Plenary 5 MINI SYMPOSIAEmerging Strategies in Extracorporeal Support
Co-chairs: Andrew Davenport, MDAmit Varma, MD
10:20-10:40 Wearable Kidney: Does it Exist?Claudio Ronco, MD
10:40-11:00 High Cut Off Membranes: Applications for CancerArthur Bradwell, MD
11:00-11:20 Diffusive Clearance of Cytokines in Sepsis? Fact or Fantasy?Ian Baldwin, RN MN ACCCN
11:20-11:35 High Volume or High Permeability Membranes forSepsis: Which Technique? Patrick Honoré, MD
11:35-11:50 SPECIAL LECTURELooking to the Future: Applying Systems Biology to Extracorporeal SupportJohn Kellum, MD, FACP
11:50-12:05 Liver Support Systems: Ready for Prime Time?Stefan Herget-Rosenthal, MD
12:05-12:35 Challenging Cases 4Emmanuel Burdmann, MD, PhD
12:35-12:50 Panel DiscussionModerator: Stuart Goldstein, MD
12:50 Closing Remarks Ravindra L. Mehta, MD, FACPChairman
12:55 Conference Adjourns
SATURDAY MORNING, MARCH 10
PROGRAM
SESSION III: TECHNIQUE CHARACTERISTICS
SESSION IV: FUTURE TRENDS IN CRRT AND CRITICAL CARE
7:00am-5:00pm Registration
Upper Grande Hall
Upper Grande Hall
11
SATURDAY AFTERNOON, MARCH 10
PROGRAM
ELECTIVE HANDS-ON WORKSHOPS
1:00-5:00 Simultaneous Elective Hands-On Workshops
12:45-1:45 Lunch Hosted by Conference for Workshop Participants - Garden Patio
1:45-3:15 SESSION 1
HO2 Fresenius Workshop “SLED , EDD and CRRT with the K Machines”Learn how to us the Fresenius system for CRRT, SLED and EDD
HO3 Gambro Prismaflex Hands-On Workshop (condensed version of H01)(closed - capacity reached)Training on setup, connections, operations, monitoring and troubleshooting for the Prismaflex platform system for patients requiring various modalities of CRRT.
HO4 CHF Solutions “The Aquadex FlexFlow System”Use of Aquapheresis and the Aquadex FlexFlow in fluid overload states.
HO5 Pediatric Hands-on WorkshopHow to prescribe and deliver CRRT for neonates and pediatric patients, including machineset up, operations, monitoring and managing alarm conditions
Timothy E. Bunchman, MDHelen Currier, BSN, RN, CNN
3:15-3:30 Coffee Break - Garden Patio
3:30-5:00 SESSION 2
5:00 Workshops Adjourn
Hanover
Garden
Crystal
Continental
Save the Dates! Mark Your Calendar Now!
CRRT 2008February 27 - March 1, 2008
Hotel del Coronado San Diego, California
for the latest info and updates:crrtonline.com
12
Patient Characteristics
Poster 1Impact of Acute Renal Failure in thePrognosis of the Critically Ill ObstetricPatientZ. Haddad, C. Kaddour
Poster 2Clinical Effects of Early High VolumeHemofiltration on Acute Renal Failure inPost-Cardiotomy PatientsD. Ji, D. Gong, B. Xu, B. Ren, Y. Liu, Z. Liu
Poster 3The Easy and Effective Way to PreventHypothermia in Acute Renal Failure Patientson Continuous VenovenousHemodiafiltrationS.-K. Park, E.Y. Im, S.J. Lee, H.S. Park, S.B. Kim
Poster 4Outcome of Acute Renal Failure amongPatients with CKDS. Samavedam, R. Chakravarthi, G. Jagatkar, P. Mohite, H. Shaistha
Poster 5The DOse REsponse MulticenterInternational Collaborative Initiative (DO-RE-MI) in Intensive Care Units (ICU) F. Mariano, M. Herrera, D. Kindgen-Milles, A. Marinho, D. Cruz, G. Monti
Poster 6Renal Failure in Leptospirosis in IndiaS. Samavedam, R. Chakravarthi, G. Jagatkar,S. Hussaini, K.V. Kamesh, R.M. Roy
Poster 7Early Changes in Organ Failures IsAssociated with the Outcomes of Critically IllPatients in Need of Renal ReplacementTherapy for Acute Kidney InjuryE. Maccariello, M. Soares, C. Valente, L. Nogueira,J.E. Machado, M. Ismael
Poster 8Performance of Six Prognostic Scores inCritically Ill Patients Receiving RenalReplacement TherapyE. Maccariello, M. Soares, C. Valente, L. Nogueira,J.E. Machado, M. Ismael
Poster 9Perioperative Factors Influencing AcuteKidney Injury in Patients following CardiacSurgeriesVarun Sundaram, G. Abraham, Vivek Sundaram, V. Sathiah, E. Bashkar, M. Mathew, S.A. Sylvester,S.P.J. Ponnusami
Poster 10Hospitalization Duration Affects Hemo-dynamic Impact of CRRT in TraumaPatientsU.Y. Bhatt, D.T. Plott, H. Sakhamuri, T. Hostetler,B. Hixon-Vermillion
Poster 11Postoperative Acute Kidney Injury Is anImportant Determinant of Long TermSurvival of Surgical PatientsS. Yavas, M.S. Segal, M. Sungur, A. Gabrielli, A.J. Layon
Poster 12The Use of Radiocontrast NephropathyProphylaxis in Critically-Ill PatientsK.W. Hatton, A. LeClaire, A.G. Winterstein, A.J. Onyenwenyi, A. Gabrielli, A.J. Layon
Poster 13AKI Classification Associated with theSeverity of Renal Injury and In-HospitalMortality in the Patients in a Cardiac Care UnitQ. Jin, X. Li, H. Wang
Emerging Concepts
Poster 14Cascade High Volume Hemofiltration:Preliminary Data in Septic Shock Patients P.N. Wiesen, M. Monchi, B.E. Dubois, J.-C.E. Preiser, P.P. Damas
Poster 15Successful Treatment of Acute Renal Failurewith Therapeutic Plasma ExchangeN.B. Blatt, T.A. Mottes, P.D. Brophy
Poster 16Effects of High Volume Hemofiltration onSevere Acute Pancreatitis in PigsD. Ji, D. Gong, B. Xu, B. Ren, Y. Liu, Z. Liu
Poster 17Clinical Effects of High VolumeHemofiltration on Severe Acute PancreatitisD. Ji, D. Gong, B. Xu, B. Ren, Y. Liu, Z. Liu
Poster 18Heparin Free Slow Low Efficiency Dialysis(SLED) Using Citrate Dialysate (CD) Is Safeand EffectiveS. Ahmad, A. Tu
Poster 19Developing Nursing Expertise in ContinuousRenal Replacement Therapy (CRRT)H.A. Odreman, M. Scaum, D. Stamant
Poster 20Evaluation of On-line Monitoring of DialysisAdequacyA. Rico, C. Stamina, L. Zhang, A. Juma,J. McDougall
Poster 21The Effect of Hemofiltration on AdultRespiratory Distress SyndromeX. Ding, J. Teng, Y. Fang, L. Chen, J. Zou, Y. Zhong
Poster 22A Randomized Prospective Study ComparingHigh Dose Continuous Venovenous -Hemo-diafiltration (CVVHDF) to Standard DoseCVVHDF in Critically Ill Patients with AcuteKidney Injury (AKI)A.J. Tolwani, R. Speer, B. Stofan, K.R. Lai, K.M. Wille
POSTER PRESENTATIONS
13
POSTER PRESENTATIONS
Emerging Concepts (continued)
Poster 23Improved Serum Urea Control in CatabolicICU Patients on CRRT using AdsorbentBased Partial Bicarbonate DialysateRecycling is Related to Urea ClearanceIndependent MechanismsJ. Stange, S. Koball, H. Hickstein, S. Mitzner, R. Schmidt, S. Schmidt, T. Szyszkowitz
Poster 24The Association Between the Variation ofSerum Creatinine and the In-HospitalMortality of Patients in a Cardiac Care UnitQ. Jin, X. Li, H. Wang
Poster 25Clinical Study of Blood Purification inPediatric Critical CareH. Kitayama, N. Wada, T. Kawasaki, M. Yamada,Y. Toyohiroo, M. Yuudai, I. Tetsuji
Poster 26Innovative Use of CRRT; Low Flow ECLSA. Divekar, R. Soni, M. Seshia, T. Drews, M. Kesselmann, G. Bonin, C. Press, M. Maas,J.Minski, T.D. Blydt-Hansen
Technique Characteristics
Poster 27Safety and Efficacy of Low Cost ModifiedPlasmapheresis in a Perepheral CentreV.R. Pachipala
Poster 28Clinical Evaluation of Anticoagulation with-out Heparin during Continuous VenovenousHemofiltrationW.X. Tang, Z.J. Chen, L. Zhou, P. Fu, S. min Huang
Poster 29High-Volume Continuous Veno-VenousHemofiltration Using Citrate AnticoagulationJ. Bouchard, P. Roy, M. Albert, S. Troyanov, F. Madore
Poster 30Safe and Rigorous Implementation of -Pulse-HVHF in ICU (100ml/kg/h): A CombinedMedical and Nursing ApproachP.M. Honore, O. Joannes-Boyau, B. Gressens, W. Boer
Poster 31Use of High-Flow Continuous Veno-VenousHemofiltration with Citrate Anticoagulationfor Maintaining Hypernatremia in a Patientwith Acute Brain and Kidney InjuryR.M. Hofmann, S.R. Sanghvi, J. Medow
Poster 32Treatment Efficiency Related to FilterLifespan, Heparine Use, Education andMachine AvailableI.V. Andersen, A. Valentin, P. Carl, J. Hansen
Poster 33Heparin-Free High Volume VenovenousHemofiltration Treatment for PerioperativePatients of Orthotopic Liver TransplantationP. Zhang, C. Li, W. Zhang, Q. He, W. XIie, H. Huang, J. Chen
Poster 34Cost-Effectiveness of Commercially AvailableSolutions in Continuous Veno-Venous Hemo-DiafiltrationY. Brahmbhatt, S. Kuo, H. Chaparala, H. Suh, N.K. Wadhwa
Poster 35Sustained Low Efficiency Dialysis (SLED)Using Regional Citrate Anticoagulation(RCA) is without Metabolic ComplicationsJ.A. Clark, G. Schulman, T.A. Golper
Poster 36Sustained Low Efficiency Dialysis (SLED)Using Regional Citrate Anticoagulation(RCA) Requires a Larger Infusion ofCalcium ChlorideJ.A. Clark, G. Schulman, T.A. Golper
Poster 37Filter Patency Is Maintained Using RegionalCitrate Anticoagulation (RCA) for SustainedLow Efficiency Dialysis (SLED), but at theCost of Increased Citrate DoseJ.A. Clark, G. Schulman, T.A. Golper
Poster 38Premature CVVH Hemofilter Failure: TheRole of Severe Hyperlipidemia ComplicatingTotal Parenteral NutritionE.A. Ross, A. Kazory, A.A. Ejaz, W.L. Clapp
Poster 39Removal of Water Soluble Toxins as OneMechanism of MARS at Different SecondaryDialysate Flow RatesJ. Stange, S. Schmidt, T. Szyszkowitz, R. Schmidt,S. Mitzner
Poster 40Solute Clearance Comparison betweenDiffusion and Pre-dilution Filtration UsingLarge Surface Area Dialyzers: In VitroStudiesJ.K. Leypoldt, C.D. Kamerath, J.F. Gilson
Poster 41Use of Commercially Available Solutions inContinuous Veno-Venous Hemo-DiafiltrationY. Brahmbhatt, H. Chaparala, S. Kuo, H. Suh,N.K. Wadhwa
Poster 42The Increased Efficacy of Citrate overHeparin Catheter-Locking in ReducingCatheter Thrombosis in HemodialysisPatientsN. Khosla, E. Lischer, J. Bestoso, W. Lester, R.L. Mehta
Poster 43Intra-Operative (IO) Continuous RenalReplacement Therapy (CRRT) utilizingRegional Citrate Anticoagulation (RCA) dur-ing Liver Transplantation: TechnicalConsiderationsR.O. Mathew, E. Lischer, R.L. Mehta
continued
14
POSTER PRESENTATIONS (continued)
CRRT Research
Poster 44Clinical Research of Prevention and Cure ofHypophosphatemia During ContinuousVenovenous HemofiltrationW.X. Tang, P. Fu, S. min Huang, L. Zhou
Poster 45Outcome of Acute Renal Failure in Those Needing Continuous RenalReplacement TherapyS.A. Hussain, M. Saleh, W.P. Piering, Y.-R. Zhu, T. Mohyuddin
Poster 46The Therapeutic Effect of High VolumeHemofililtrition in Severe Acute PancreatitisJ. Tian, W. Xian, X. Cui, H. Sun, L. Xiong
Poster 47The Effect of Artificial Liver on SerumCytokines in Pig Model of Fulminant Hepatic FailureJ. Tian, L. Geng, L. Xiong, Y. Ma, Z. Duan
Future Trends
Poster 48Establishment of a Community-WideContinuous Renal Replacement TherapyCenter of Excellence Program: A TeamApproach using Data CollectionS. Shelton, L. Mitchell, C.W. Old, A. Collins
Poster 49Nursing Education and CompetencyVerification for CRRTN. Henderson, Y. Avent
Poster 50A Study of Bilirubin Kinetics During theMolecular Adsorbent Recirculating SystemTherapiesD. Gong, J. Daxi, T. Jing, X. Bin, R. Bing,L. Leishi
Poster 51Dose Predictions for Combined Treatment ofHemofiltration with HemodialysisB.G. Min, J.C. Lee
Poster 52Access for Wrist and Forearm WearableArtificial Kidney, Pancreas and LiverA.J. Lande
Poster 53The Use of Xigris in Prolongation ofContinuous Renal Replacement Therapy(CRRT) Filter LifeL.R. Grier, R. Pintado, M.S. Jordan
15
GENERAL WORKSHOPS AT A GLANCE
WORKSHOP Group 1 Thursday 8:00-9:30amCode TitleA01* CRRT Systems I (C,N,AP)B02 Dialysis Dose Prescription and
Delivery 1 (C,N)C03 Vascular Access /Membrane and
Circuit 1 (C,N,AP)D04 Resuscitation 1 (C,N,AP)E05 Pediatric CRRT: The Basics (I,N,AP)F06 Extracorporeal Techniques for Sepsis 1(A) G07 Plasma Exchange Therapy and
Hybrid Techniques 1 (A)
WORKSHOP Group 2 Thursday 9:45-11:15am Code TitleA08* CRRT Systems II (C,N,AP)B09 Anticoagulation 1: Mechanisms & Tech.(C)C10 Fluid Management 1 (I,N,AP)D11 Acid Base and Electrolyte Problesm in
the Critically Ill 1 (I,N,AP)E12 Organizational Aspects of
CRRT Programs 1 (C,N,AP)F13 Heart Failure & Cardio-Renal Syndrome1 (I) G14 Therapy Comparisons I:
SLED vs. CRRT vs. PD (I,N,AP)
WORKSHOP Group 3 Thursday 12:45-2:15pm Code TitleA15* CRRT Systems III (C,N,AP)B16 Solutions for CRRT 1 (I,N)C17 Drug Management 1 (I,N,AP)D18 Nutritional Assessment and Support 1 (I,N)E19 A Systems-based Approach to
CRRT 1 (A,N,AP)F20 Liver and the Kidney 1 (A)G21 Biomarkers 1 (I,N)
WORKSHOP Group 4 Thursday pm 2:30-4:00pmCode TitleA22* CRRT Systems I (C,N,AP)B23 Dialysis Dose Prescription and
Delivery 2 (I)C24 Vascular Access/Membrane and
Circuit 2 (C,N,AP)D25 Resuscitation 2 (A,N,AP)E26 CRRT in the New Born (I,N,AP)F27 Extracorporeal Techniques for Sepsis 2 (A)G28 Plasma Exchange Therapy and
Hybrid Techniques 2 (A)
WORKSHOP Group 5 Friday 2:15-3:45pm Code TitleA29* CRRT Systems II (C,N,AP)B30 Anticoagulation 2: Special Tech. Citrate (A)C31 Fluid Management 2 (I,N,AP)D32 Acid Base and Electrolyte Problems in
the Critically Ill 2 (A)E33 Organizational Aspects of
CRRT Programs 2 (C,N,AP)F34 Heart Failure and Cardio-renal Syndrome 2 (A)G35 Therapy Comparisons 2:
SLED vs. CRRT vs. PD (A)
WORKSHOP Group 6 Friday 4:00-5:30pm Code TitleA36* CRRT Systems III (C,N,AP)B37 Solutions for CRRT 2 (A)C38 Drug Management 2 (I,N)D39 Nutritional Assessment and Support 2 (I)E40 A Systems-based Approach to
CRRT 2 (A,N,AP)F41 Liver and Kidney II: Hepatic Support (A)G42 Biomarkers 2 (A)
To add or change workshops, please visit the registration desk. Some workshops may not be avail-able because they have reached their room capacity.
Codes C = Core workshopI = Intermediate,A = AdvancedN = NursesAP = (of interest to nurses and allied personnel)
Workshops with and asterisk are repeated. Workshops label with a “2” are meant to complimentthe first part of the workshop (labeled “1”) but they are also suited for registrants that have notattended part 1.
16
WEST PARKING
MAINENTRANCE
PAC
IFIC
OC
EA
N
PARKING
MAINLOBBY
GARDENPATIO
BALLROOM
OCEANTOWERS
Workshop(Hanover)
Workshop(Garden Room)
Lunch Friday
Meet the Faculty/Big Band and
Swing Dance Reception(Crown Room)
Workshop(Crystal)
WorkshopsWindsor Complex
(Windsor) (Embassy)
Workshop(Continental)
Coffee Breaks forThursday &
Saturday Workshops
Saturday WorhshopLuncheon
(Garden Patio)
➮
California CabanasWorkshops
(Coastal Surf)(Pacific Tide)
(Palm)
(Sunset)
WINDSOR LAWN
LunchThursday
OR
AN
GE
AV
EN
UE
GRANDE HALL
LOWER LEVEL
UPPER LEVELPlenary Sessions
(Upper Grande Hall)
RegistrationWed. 5:30-8:00pm
Thur./Fri./Sat. 7:00am-5:00pm(Upper Grande Hall Foyer)
Posters(Upper Grande Hall)
Exhibits/Coffee Breaks(Spreckles Complex)
Speaker Ready RoomThur. pm/Fri./Sat.
(Board Room)
Exhibits/Coffee Breaks(Wilder Complex)
Exhibits/Coffee Breaks(Edison Complex)
Welcome Reception(Wilder Complex)
ACKNOWLEDGEMENTS
The Twelfth International Conference on Continuous Renal Replacement Therapies would like to acknowledge the support of the CRRT Conference by the following:
PATRON
Baxter & Edwards Critical Care Nephrology Alliance
Gambro
SPONSOR
Biosite
CHF Solutions
Fresenius Medical Care
SUPPORTER
B. Braun Medical Incorporated
Dialysis Solutions Incorporated
NxStage Medical Incorporated
CONTRUBUTOR
Genzyme
Roche
DONOR
Advanced Renal Technologies
American Regent Incorporated
Amgen
The Binding Site Incorporated
Clinical Nephrology
Elsevier Publishing
Health Informatics Incorporated
Karger
Ortho Biotech Incorporated
TNT Moberg International Ltd.
Tyco Healthcare / Kendall